Everyone seems to be ignoring the political consequences of NOT approving AGVHD at this point.
Without approval for AGVHD it's not a simple label extension for Covid-19 / ARDS in three weeks time. The political optics of recommending for Covid-19 / ARDS (admittedly from a very clear cut quad blinded phase3 trial) but requiring yet another trial for the sick children, is horrible.
Remember that the FDA can approve regardless of the AdCom result... The bodies are stacking up in the meantime.
[ Not that I think the AdCom result will be negative ]
Ann: Update on Scheduled FDA Advisory Committee Meeting, page-177
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.06 |
Change
-0.030(2.75%) |
Mkt cap ! $1.267B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.13 | $1.05 | $5.560M | 5.097M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 145674 | $1.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.06 | 28826 | 8 |
View Market Depth
| Last trade - 13.34pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.06 |
Change
-0.030 ( 3.29 %) |
||||
| Open | High | Low | Volume | ||
| $1.09 | $1.13 | $1.05 | 1233327 | ||
| Last updated 13.53pm 10/05/2024 ? | |||||
| MSB (ASX) Chart |